F, P., E, B., MC, M., G, C., M, D., AM, F., . . . M, C. (2025). Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantation. British journal of haematology, 206(3), 924. https://doi.org/10.1111/bjh.19976
Chicago Style (17th ed.) CitationF, Perutelli, et al. "Venetoclax Therapy in Chronic Lymphocytic Leukaemia Patients Relapsed After Allogeneic Haematopoietic Stem Cell Transplantation." British Journal of Haematology 206, no. 3 (2025): 924. https://doi.org/10.1111/bjh.19976.
MLA (9th ed.) CitationF, Perutelli, et al. "Venetoclax Therapy in Chronic Lymphocytic Leukaemia Patients Relapsed After Allogeneic Haematopoietic Stem Cell Transplantation." British Journal of Haematology, vol. 206, no. 3, 2025, p. 924, https://doi.org/10.1111/bjh.19976.